...
首页> 外文期刊>The journal of immunology >Presence of Diabetes-Inhibiting, Glutamic Acid Decarboxylase-Specific, IL-10-Dependent, Regulatory T Cells in Naive Nonobese Diabetic Mice
【24h】

Presence of Diabetes-Inhibiting, Glutamic Acid Decarboxylase-Specific, IL-10-Dependent, Regulatory T Cells in Naive Nonobese Diabetic Mice

机译:幼稚非肥胖糖尿病小鼠中存在糖尿病抑制,谷氨酸脱羧酶特异性,IL-10依赖性调节性T细胞的存在

获取原文
           

摘要

Immunization of NOD mice with autoantigens such as glutamic acid decarboxylase (GAD) 221–235 peptide (p221) can induce Ag-specific CD4+ T regulatory (Tr) cells. However, it is unclear whether these Tr cells acquire their regulatory capacity due to immunization or whether they are constitutively harbored in unimmunized naive mice. To address this question, we used an I-Ag7 tetramer to isolate p221-specific T cells from naive NOD mice (N221+ cells) after peptide-specific in vitro expansion. The N221+ T cells produced IFN-γ and IL-10, but very little IL-4, in response to p221 stimulation. These T cells could function as regulatory cells and inhibit in vitro proliferation of diabetogenic BDC2.5 cells. This suppressive activity was cell contact-independent and was abrogated by Abs to IL-10 or IL-10R. Interestingly, IL-2 produced by other T cells present in the cell culture induced unactivated N221+ T cells to exhibit regulatory activities involving production of IL-10. In vivo, N221+ cells inhibited diabetes development when cotransferred with NOD splenocytes into NOD/ scid recipients. Together, these results demonstrate that p221-specific IL-10-dependent Tr cells, including Tr type 1 cells, are present in naive NOD mice. The use of spontaneously arising populations of GAD peptide-specific Tr cells may represent a promising immunotherapeutic approach for preventing type 1 diabetes.
机译:用诸如谷氨酸脱羧酶(GAD)221–235肽(p221)等自身抗原对NOD小鼠进行免疫可以诱导Ag特异性CD4 + T调节(Tr)细胞。但是,目前尚不清楚这些Tr细胞是否由于免疫获得了调节能力,或者是否在非免疫幼鼠中组成性地藏有它们。为了解决这个问题,我们使用I-Ag7四聚体从肽特异性体外扩增后的幼稚NOD小鼠(N221 +细胞)中分离出p221特异性T细胞。响应p221刺激,N221 + T细胞产生IFN-γ和IL-10,但很少产生IL-4。这些T细胞可作为调节细胞并抑制糖尿病性BDC2.5细胞的体外增殖。该抑制活性是不依赖细胞接触的,并且被Abs废除了IL-10或IL-10R。有趣的是,细胞培养物中存在的其他T细胞产生的IL-2诱导未激活的N221 + T细胞表现出涉及IL-10产生的调节活性。在体内,与NOD脾细胞共转移到NOD / scid受体中时,N221 +细胞抑制了糖尿病的发展。总之,这些结果表明,幼稚的NOD小鼠中存在p221特异性的IL-10依赖性Tr细胞,包括1型Tr细胞。自发产生的GAD肽特异性Tr细胞群体的使用可能代表了一种有希望的预防1型糖尿病的免疫治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号